Biotech takes aim at large anti-estrogen markets.
Hollmer
Mark
M
D001709:Biotechnology / Q000191:economics*; D002986:Clinical Trials as Topic; D004345:Drug Industry / Q000191:economics*; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D006801:Humans; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects / Q000138:chemical synthesis / Q000191:economics*
D020845:Selective Estrogen Receptor Modulators